Lung Cancer Screening in Patients with COPD—A Case Report
AbstractWe present two cases demonstrating the nuances that must be considered when determining if a patient could benefit from low dose computed tomography (LDCT) lung cancer screening. Our case report discusses the available literature, where it exists, on lung cancer screening with special attention to the impact of chronic obstructive pulmonary disease (COPD), and poor functional status. Patients with COPD and concurrent smoking history are at higher risk of lung cancer and may therefore benefit from lung cancer screening. However, this population is at increased risk for complications related to biopsies and lobar resections. Appropriate interventions other than surgical resection exist for COPD patients with poor pulmonary reserve. Risks and benefits of lung cancer screening are unique to each patient and require shared decision-making. View Full-Text
Share & Cite This Article
Amirahmadi, R., M.D.; Kumar, A.J., M.D.; Cowan, M., M.D.; Deepak, J., M.B.B.S., FACP. Lung Cancer Screening in Patients with COPD—A Case Report. Medicina 2019, 55, 364.
Amirahmadi R, MD, Kumar AJ, MD, Cowan M, MD, Deepak J, MBBS, FACP. Lung Cancer Screening in Patients with COPD—A Case Report. Medicina. 2019; 55(7):364.Chicago/Turabian Style
Amirahmadi, Roxana, M.D.; Kumar, Avnee J., M.D.; Cowan, Mark, M.D.; Deepak, Janaki, M.B.B.S., FACP. 2019. "Lung Cancer Screening in Patients with COPD—A Case Report." Medicina 55, no. 7: 364.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.